Latest Post

December 29, 2016

West Expands Capabilities in Container Closure Integrity - HVLD

<p>Integrity of a drug product container/delivery system is essential to guarantee safety and efficacy. USP has recently issued <em>Chapter &lt;1207&gt; &ldquo;Package Integrity Evaluation &ndash; Sterile Products&rdquo;</em>&mdash;a guidance for the pharmaceutical industry in measuring container closure integrity (CCI). In line with this guidance, West has just expanded its capability in measuring CCI by adding<strong> high-voltage leak detection (HVLD)</strong> &ndash;a method endorsed in Chapter &lt;1207&gt;. </p> <p>&nbsp;</p> <br>
West Pharma

Philomina Albanese

Director, Laboratory Operations

Categories

Search the Blog

Archive